NEW JERSEY (Ivanhoe Newswire) – Colorectal cancer is the fourth leading cause of cancer in the United States. Because Americans have been getting colon cancer at a younger age, the recommended age for a colonoscopy has dropped in recent years from 50 to age 45. Now, new technology is detecting more potential cancers than ever before.
Twinique Wright celebrated her 49th birthday with family and friends knowing a milestone year was on the horizon. For Wright, it was past time to get the health screening she had been avoiding – a colonoscopy.
“Every time, I said, ‘Okay, well, I get it done next year or next year, next year.’ It’s four years later. So, I said, ‘No, I have to do it,” Wright tells Ivanhoe.
Wright didn’t know when she scheduled her screening that doctors were using new technology, a smart tool called the G.I. Genius, which uses artificial intelligence during the procedure.
Hackensack University Medical Center’s Chief of Gastroenterology, Dr. Rosario Ligresti, MD explains, “It’s a box that actually interprets every image, every frame of the colonoscopy in real time, and alerts the physician in real time on the screen by a little green box at a little buzzer where it thinks there’s a polyp.”
Then, the doctor inserts a tiny tool into the scope to remove any polyps.
“We know that the increase in adenoma detection rate, the increase of the ability of the doctor to find more polyps decreases the patient’s risk of getting colon cancer. By adding G.I. Genius, you’re increasing the adenoma detection rate by 14 percent,” Dr. Ligresti further explains.
Dr. Howard Ross, MD, a colon surgeon at the Hackensack University Medical Center, adds, “The additional tool doesn’t change the nature of the procedure for them. So, it’s not any harder. It doesn’t hurt, it doesn’t change what’s actually happening at colonoscopy.”
Wright’s doctors found nothing suspicious during her screening. For her, something else to celebrate.
“I feel at ease and I’m happy I did get it done and that just made it that much better,” she expresses.
The G.I. Genius was FDA-approved in 2021. Dr. Ligresti says the procedure with the new technology might be just a few minutes longer, but otherwise, there is absolutely no difference for the patient. The G.I. Genius is covered in the same way a screening colonoscopy is covered by insurance, so there’s no additional cost to the patient.
Contributors to this news report include: Cyndy McGrath, Producer; Kirk Manson, Videographer; Roque Correa, Editor.
To receive a free weekly e-mail on medical breakthroughs from Ivanhoe, sign up at: http://www.ivanhoe.com/ftk
Source:
MEDICAL BREAKTHROUGHS
RESEARCH SUMMARY
TOPIC: G.I. GENIUS: SMART COLONOSCOPY
REPORT: MB #5175
BACKGROUND: Colorectal cancer is the fourth leading cause of death among men and women. In 2019, 51,000 people died of colorectal cancer. This type of illness affects people of all ages and ethnic backgrounds. While increasing age is a risk factor, many Americans at younger ages are at a growing risk as well. Though rates in men and women are similar, women statistically have a longer life expectancy. Sixty five percent of people diagnosed with colorectal cancer have a five- year survival rate.
(Source:
https://seer.cancer.gov/statfacts/html/colorect.html
https://www.cdc.gov/cancer/colorectal/statistics/index.htm
DIAGNOSING: When diagnosing, doctors will use a scope to examine the inside of your colon; the procedure is called a colonoscopy. A doctor may also order a blood test. While blood tests cannot define the cancer, they can detect other problems within the body such as kidney and liver health and functions. A doctor will recommend further tests to determine the stage of the cancer. Staging tests can involve things like CT scans. Stage IV means the disease has metastasized and spread to other parts of the body. Colonoscopies look for differences in swelling, irritated tissues, and cancers. Polyps are also done during colonoscopies and are performed to reduce the risk of colon cancers.
(Source:
https://www.mayoclinic.org/diseases-conditions/colon-cancer/diagnosis-treatment/drc-20353674
NEW TECHNOLOGY: In recent years the Food and Drug Administration has approved the GI Genius. This is the first ever device that uses artificial intelligence to help professionals detect polyps or tumors in the colon during a colonoscopy. The GI Genuis is made up of hardware and software that detect potential risks. It uses artificial intelligence to locate affected or problem areas. It sends signals to the medical professional during examination that some areas of the colon require further assessment and testing. The device is made to be compatible with many other FDA devices and endoscopy systems.
(Source:
FOR MORE INFORMATION ON THIS REPORT, PLEASE CONTACT:
Edna Arguello
(201) 525-8833
If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas at mthomas@ivanhoe.com
